21 results
8-K
EX-10.3
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY … ) for purposes of the Option, Participant’s engagement as a Service Provider will be considered terminated as of the date Participant is no longer
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
engagement with FDA to finalize the regulatory path for the device.
Continued development across several preclinical studies for the Company’s nsPFA
8-K
EX-99.1
wd9e4
10 Aug 22
Pulse Biosciences Reports Second Quarter 2022 Financial Results
4:15pm
8-K
EX-10.1
ewqvhjq7zz00pv8v6zpv
10 Jun 21
Other Events
4:41pm
8-K
EX-99.1
3q3fmybomzz6t3j0qxs
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm
CORRESP
2dz8l3
14 Apr 20
Correspondence with SEC
12:00am
8-K12B
EX-3.4
w88ca8dked5y
18 Jun 18
Notification of registration of securities
4:55pm
8-K12B
EX-10.1
n1xwbb2v
18 Jun 18
Notification of registration of securities
4:55pm
10-K
EX-10.1
e0pm273vbvlw 2vm0wa
20 Mar 17
Annual report
12:00am